| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |